Domestic Shifts, Global Impacts: Manufacturing, Courts, and Deregulation
New executive order targets domestic drug production as court and regulatory actions continue to evolve.
Key developments this week include an Executive Order promoting domestic pharmaceutical manufacturing that may influence PDUFA negotiations and impact MedTech. AdvaMed continues monitoring the Supreme Court’s review of Kennedy v. Braidwood, with a webinar planned post-decision. Additional updates include recordings of the Nairobi Protocol webinar, ongoing analysis of federal procurement reform orders, and multiple RFIs from OMB, DOJ, FTC, and CMS related to deregulation and regulatory relief. Members are invited to share insights and contribute to upcoming comment submissions.
Explore the latest updates and see how you can get involved in our response strategy.